Product Images Renvela

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Renvela NDC 68151-5113 by Carilion Materials Management, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label Image - lbl681515113

Label Image - lbl681515113

Renvela is a medication containing sevelamer carbonate manufactured by Genzyme. This medication comes in the form of an 800 mg tablet and is associated with the lot number B3548B01 and the expiration date of 09/14. The remaining text is not readable due to errors.*

Chemical Structure/Figure 1 - renvela 01

Chemical Structure/Figure 1 - renvela 01

This appears to be a diagram showing the chemical structure of a molecule consisting of two amino groups (NH2) connected by a single nitrogen atom (NH) and a hydroxyl group (OH). The compound is not specified, but it is likely an organic molecule.*

Figure 2 - renvela 02

Figure 2 - renvela 02

This appears to be a graph or chart displaying the reduction of serum phosphorus levels in patients using Sevelamer Hydrochloride compared to an active control. The graph contains information on the percentage of patients who experienced improvement or worsened levels of serum phosphorus and the reduction from the baseline. The X-axis displays the reduction in serum phosphorus levels (measured in mg/dL) while the Y-axis appears to be a combination of patient numbers and various labels that are not clear due to the output.*

Figure 3 - renvela 03

Figure 3 - renvela 03

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.